îæ€çŽ¢
îæ€çŽ¢
î
NRX Pharmaceuticals Inc
NRXPîãŠã©ãããªã¹ãã«è¿œå
3.320USD
-0.070-2.06%
çµå€Â 09-18 16:00ïŒETïŒ
144.58Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
æ ªäž»
æŽæ°æå»: Sun, May 10
æŽæ°æå»: Sun, May 10
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Anson Funds Management LP.
9.21%
B Group, Inc.
9.07%
Javitt (Jonathan C)
4.59%
Vanguard Capital Management, LLC
3.51%
Glytech LLC
2.91%
ä»ã®
70.71%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Anson Funds Management LP.
9.21%
B Group, Inc.
9.07%
Javitt (Jonathan C)
4.59%
Vanguard Capital Management, LLC
3.51%
Glytech LLC
2.91%
ä»ã®
70.71%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Investment Advisor
16.89%
Hedge Fund
9.31%
Individual Investor
5.39%
Corporation
2.91%
Investment Advisor/Hedge Fund
1.03%
Research Firm
0.14%
Bank and Trust
0.08%
ä»ã®
64.26%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Apr 1
æŽæ°æå»: Wed, Apr 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
74
9.80M
29.64%
+5.09M
2025Q4
67
7.14M
25.42%
+3.67M
2025Q3
66
6.31M
26.53%
+3.75M
2025Q2
66
5.07M
29.31%
+1.44M
2025Q1
66
4.06M
26.08%
+505.82K
2024Q4
70
3.94M
22.32%
-356.61K
2024Q3
83
3.57M
28.23%
-628.46K
2024Q2
86
3.38M
32.03%
-634.67K
2024Q1
92
3.27M
34.30%
-835.14K
2023Q4
98
3.31M
81.28%
-805.62K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Anson Funds Management LP.
3.04M
9.21%
+1.02M
+50.31%
Dec 31, 2025
B Group, Inc.
3.00M
9.07%
+3.00M
--
Aug 18, 2025
Javitt (Jonathan C)
1.52M
4.59%
--
--
Feb 12, 2026
Glytech LLC
963.48K
2.91%
--
--
Feb 12, 2026
AdvisorShares Investments, LLC
328.00K
0.99%
-14.13K
-4.13%
Dec 31, 2025
Commonwealth Financial Network
366.63K
1.11%
+366.63K
--
Dec 31, 2025
Hurvitz (Chaim)
221.48K
0.67%
--
--
Feb 12, 2026
Geode Capital Management, L.L.C.
218.87K
0.66%
+33.00K
+17.76%
Dec 31, 2025
詳现ãèŠã
ETFåžå Ž
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
AdvisorShares Psychedelics ETF
6.62%
iShares Micro-Cap ETF
0.01%
AdvisorShares Psychedelics ETF
æ¯ç6.62%
iShares Micro-Cap ETF
æ¯ç0.01%